Data / Drug companies / Oxycodone and acetaminophen
Oxycodone and acetaminophen: 32 companies and 118 products in the FDA NDC directory
Oxycodone and acetaminophen is listed in the FDA National Drug Code Directory by 32 companies, with 118 products in commercial distribution. 118 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution, and the newest product started marketing on August 21, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 32
- Products
- 118
- Generic (ANDA) products
- 118 (100.0%)
- Application numbers
- 15
- Controlled substance schedule
- Schedule II
- Routes
- Oral
- Brand names
- Endocet, Prolate, Nalocet
- openFDA record search
- api.fda.gov
Companies that list oxycodone and acetaminophen
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 16 | tablet | Generic drugs (ANDA) | June 1, 2019 |
| Camber Pharmaceuticals, Inc. | 8 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| Asclemed USA, Inc. | 6 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| Proficient Rx LP | 6 | tablet | Generic drugs (ANDA) | December 1, 2016 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| KVK-Tech, Inc. | 5 | tablet; solution | Generic drugs (ANDA) | December 5, 2019 |
| Aurolife Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | July 15, 2013 |
| Forte Bio-Pharma LLC | 4 | tablet | Generic drugs (ANDA) | February 17, 2020 |
| Granules Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | January 1, 2022 |
| Lupin Pharmaceuticals,Inc. | 4 | tablet | Generic drugs (ANDA) | February 24, 2017 |
| Par Health USA, LLC | 4 | tablet | Generic drugs (ANDA) | March 6, 2003 |
| XLCare Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| Alvogen Inc. | 3 | tablet | Generic drugs (ANDA) | March 9, 2016 |
| Asclemed USA Inc. | 3 | tablet | Generic drugs (ANDA) | June 1, 2019 |
| AvPAK | 3 | tablet | Generic drugs (ANDA) | July 9, 2018 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | August 28, 2014 |
| Direct_Rx | 3 | tablet | Generic drugs (ANDA) | July 28, 2022 |
| Epic Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | July 2, 2018 |
| Eywa Pharma Inc | 3 | tablet | Generic drugs (ANDA) | June 1, 2019 |
| Major Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | June 1, 2019 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | April 11, 2017 |
| Rhodes Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | August 28, 2014 |
| St. Mary's Medical Park Pharmacy | 3 | tablet | Generic drugs (ANDA) | August 21, 2025 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | June 6, 2014 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | November 27, 2007 |
| FH2 Pharma LLC | 2 | tablet | Generic drugs (ANDA) | March 2, 2021 |
| Redpharm Drug | 2 | tablet | Generic drugs (ANDA) | August 28, 2014 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | January 4, 2022 |
| Amneal Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | November 1, 2013 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | August 21, 2019 |
| Quality Care Products LLC | 1 | tablet | Generic drugs (ANDA) | June 10, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 117 | 99.2% |
| Solution | 1 | 0.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 118 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Opioid Agonist | 118 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.